Clinical Trials on Glaucoma and Concomitant Dry Eye Syndrome in Belgium

Total 56 results

Universitaire Ziekenhuizen KU Leuven

Completed

Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

Open Angle Glaucoma

Belgium
Alcon Research

Terminated

DuoTrav APS Versus XALACOM® in Ocular Surface Health

Ocular Hypertension | Open Angle Glaucoma

Belgium
Allergan

Completed

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Dry Eye Disease

France, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
Universitaire Ziekenhuizen KU Leuven

Unknown

Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients

Open Angle Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation

Open Angle Glaucoma | Low Tension Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow

Open Angle Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface Symptoms

Open Angle Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients

Open-angle Glaucoma | Low Tension Glaucoma

Belgium
Alcon Research

Completed

A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-angle

Belgium
Universitaire Ziekenhuizen KU Leuven
FRO (Funds for Research in Ophthalmology, Belgium)

Unknown

Metabolomics in Surgical Ophthalmological Patients (MISO)

Low Tension Glaucoma | Primary Open-angle Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study

Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
Universitaire Ziekenhuizen KU Leuven

Unknown

Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins

Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma

Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
Allergan

Completed

Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Open-Angle Glaucoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Correlation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle Glaucoma

Primary Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
EyeTechCare

Completed

Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients

Glaucoma

Belgium, Israel, Italy, Portugal
EyeD Pharma

Recruiting

Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma

Primary Open-angle Glaucoma

Germany, Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer

Glaucoma

Belgium
iSTAR Medical

Completed

STARflo European Safety and Efficacy Study

Open Angle Glaucoma

Belgium, Germany, Bulgaria, France, Switzerland
iSTAR Medical

Active, not recruiting

STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

Open Angle Glaucoma

Spain, Germany, Belgium, France, Hungary
argenx
Iqvia Pty Ltd

Completed

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) (rho)

Primary Sjögren's Syndrome

Belgium, Poland, Hungary, Netherlands
Universitaire Ziekenhuizen KU Leuven

Completed

Astigmatism Post-trabeculectomy

Glaucoma

Belgium
Alcon Research

Terminated

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

Ocular Hypertension | Glaucoma

Belgium
Sensimed AG

Completed

SENSIMED Triggerfish

Glaucoma

Spain, Belgium, Switzerland, Denmark
AqueSys, Inc.

Completed

Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants

Primary Open Angle Glaucoma

Spain, Austria, Belgium, Italy, Germany, Poland, Switzerland, United Kingdom, Venezuela
Universitaire Ziekenhuizen KU Leuven

Unknown

Vitreopapillary Interface and Optic Disc Morphology

Glaucoma | Posterior Vitreous Detachment | Vitreomacular Traction | Vitreopapillary Traction

Belgium
Universitaire Ziekenhuizen KU Leuven
Funding for Research in Ophthalmology (FRO)

Completed

Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes

Fibrosis | Glaucoma | Intraocular Pressure | Trabeculectomy

Belgium
Universitaire Ziekenhuizen KU Leuven
Allergan

Unknown

Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml (SPORTII)

Ocular Hypertension | Glaucoma

Belgium, Austria, Italy, Switzerland, United Kingdom
Novartis Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (LOUiSSe)

Sjögren Syndrome

Spain, United States, Belgium, Hungary, Germany, Switzerland, Australia, Denmark, China, Taiwan, United Kingdom, Bulgaria
Universitaire Ziekenhuizen KU Leuven
Santen Oy

Completed

Prevalence of Glaucoma in Belgium: a Multicenter National Trial (BelGlaucoma)

Glaucoma

Belgium
Devogelaere Vision

Completed

Effect of Vitamin Supplementation in Glaucoma Patients

Glaucoma | Homocysteinemia | Elevated Retinal Venous Pressure | Abnormal Steady State Pattern Electroretinography

Belgium
Omikron Italia S.r.l.

Completed

Study of Neurotidine® Intake on Life Quality of Patients With Glaucoma

Glaucoma

Belgium, Greece, Italy, Spain
Sanofi

Completed

Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

Sjogren's Syndrome | Sjögren's Syndrome

Belgium, Taiwan, Korea, Republic of, United States, Argentina, Canada, Chile, France, Germany, Hungary, Mexico, Spain
Novartis Pharmaceuticals

Completed

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Primary Sjogren Syndrome

United States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
Novartis Pharmaceuticals

Recruiting

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

Sjogren Syndrome

Brazil, Portugal, United States, Belgium, Spain, Germany, Korea, Republic of, Czechia, Mexico, France, Turkey, China, Guatemala, Austria, Chile, Poland, Singapore, Lithuania
Allergan

Completed

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States, Israel, Canada, Singapore, Philippines, Spain, Australia, Belgium, Brazil, Germany
Sun Pharmaceutical Industries Limited

Completed

A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

India, Russian Federation
Aerie Pharmaceuticals

Completed

Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United Kingdom, Spain, Austria, Belgium, Czechia, France, Germany, Hungary, Italy, Latvia, Poland
Novartis Pharmaceuticals

Recruiting

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. (NEPTUNUS-Ext)

Sjogrens Syndrome

United States, Spain, Austria, Belgium, Japan, Germany, Turkey, Hungary, Israel, Taiwan, Italy, France, Colombia, Argentina, Portugal, Australia, Slovakia, United Kingdom, Guatemala, Brazil, Czechia, Poland, Bulgaria, Canada, Lithuania, R...
Hoffmann-La Roche

Completed

PRM-151 in the Prevention of Scarring Following Trabeculectomy

Glaucoma

United Kingdom, Belgium, Czechia, Netherlands
Universitaire Ziekenhuizen KU Leuven

Unknown

Structural Orbital Changes in Anophthalmic Socket Syndrome

Anophthalmos; Acquired | Anophthalmic Socket Syndrome

Belgium
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study (SPORT)

Ocular Hypertension | Glaucoma

United Kingdom, Switzerland, Belgium, Italy, Portugal, Austria
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

Sjögren's Syndrome

United States, Australia, Germany, Korea, Republic of, Austria, China, Spain, Japan, Puerto Rico, Poland, Canada, Hungary, Chile, Denmark, France, Italy, Mexico, Peru, Netherlands, Belgium, Brazil, Colombia, United Kingdom, Portugal, Sw... and more
AbbVie

Enrolling by invitation

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Maia)

Ocular Hypertension | Open-Angle Glaucoma

United States, Argentina, Belgium, Brazil, Canada, Colombia, Czechia, Denmark, Egypt, France, Germany, Hong Kong, Italy, Korea, Republic of, New Zealand, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Thailan... and more
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long-Term Non-Interventional Latanoprost Study (LYNX)

Ocular Hypertension | Glaucoma

Spain, Czechia, Sweden, Germany, France, Greece, Belgium, Colombia, Denmark, Italy, Peru, Portugal, Slovakia, United Kingdom
Pfizer

Completed

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

France, Greece, Ireland, Spain, Sweden, United Kingdom, Belgium, Italy, Netherlands, Germany, Australia, Denmark
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.

Glaucoma

United States, Spain, Serbia, Ukraine, Belgium, Italy, Portugal, France, Slovenia, Germany, Poland, Czechia, Philippines, Colombia, India, Romania, Russian Federation, Slovakia, South Africa, United Kingdom
Bristol-Myers Squibb

Completed

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's Syndrome

United States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom
Allergan

Completed

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Hong Kong, Taiwan, Spain, Israel, Australia, Austria, Belgium, Brazil, Denmark, Hungary, Peru, Philippines, Poland

Clinical Trials on Glaucoma and Concomitant Dry Eye Syndrome in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations